📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A Temporizing Solution to "Artemisinin Resistance". (2019)

First Author: Chan XS

Attributed to: The Cardiovascular Toxicity of Antimalarial Drugs funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1056/nejmc1909337

PubMed Identifier: 31483979

Publication URI: http://europepmc.org/abstract/MED/31483979

Type: Journal Article/Review

Volume: 381

Parent Publication: The New England journal of medicine

Issue: 10

ISSN: 0028-4793